SAB Biotherapeutics (SABS) Property, Plant & Equipment (Net) (2020 - 2026)

SAB Biotherapeutics (SABS) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	66,320.50 Bn	66,320.21 Bn	-	642,333.36
2	Nanobiotix	1,933.82 Bn	1,933.76 Bn	-	5.32 Mn
3	Akari Therapeutics	1,022.34 Bn	1,022.34 Bn	-	-
4	BeOne Medicines	472.93 Bn	468.14 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	122.22 Bn	114.98 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	69.96 Bn	61.21 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.66 Bn	62.66 Bn	-	-
8	Argenx Se	56.07 Bn	50.89 Bn	1.41 Bn	1.96 Bn
9	Alnylam Pharmaceuticals	37.60 Bn	34.59 Bn	959.66 Mn	518.26 Mn
10	SAB Biotherapeutics	188.53 Mn	188.53 Mn	-	13.81 Mn

Download Data